Senti Biosciences Files S-8 POS for Employee Stock Plans
Ticker: SNTI · Form: S · Filed: Apr 24, 2026 · CIK: 0001854270
Sentiment: neutral
Topics: employee-benefits, registration-statement, stock-plan
TL;DR
Senti Bio filed S-8 POS for employee stock plans on 4/24/26.
AI Summary
Senti Biosciences, Inc. filed an S-8 POS form on April 24, 2026, registering an unspecified number of securities to be offered under its employee benefit plans. This filing is a post-effective amendment, indicating updates or additions to previously registered securities for employee compensation.
Why It Matters
This filing relates to the company's ability to issue stock to employees, which can impact future dilution and employee compensation strategies.
Risk Assessment
Risk Level: low — This is a routine administrative filing related to employee stock plans and does not represent a new financial event or material change.
Key Players & Entities
- Senti Biosciences, Inc. (company) — Filer
- 0001854270 (company) — CIK
- 2026-04-24 (date) — Filing Date
FAQ
What type of filing is this?
This is an S-8 POS filing, which is a registration statement for securities to be offered to employees in connection with employee benefit plans, and it is a post-effective amendment.
Who is the filer?
The filer is Senti Biosciences, Inc.
When was this filing made?
The filing date was April 24, 2026.
What is the CIK number for Senti Biosciences, Inc.?
The CIK number for Senti Biosciences, Inc. is 0001854270.
What is the primary purpose of an S-8 POS filing?
An S-8 POS filing is used to register securities that a company intends to offer to its employees under various employee benefit plans.
Filing Details
This Form S (Form S) was filed with the SEC on April 24, 2026 regarding 8 POS - Senti Biosciences, Inc. (SNTI).